FDA Approved: TIROFIBAN — Original Application (Eugia US LLC)

View source ↗

Summary

The FDA approved Eugia US LLC's original Abbreviated New Drug Application for tirofiban, granting approval of a generic version of the anti-platelet drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• tirofiban (tirofiban)

Snippet

ORIG AP for TIROFIBAN (TIROFIBAN)